Skip to content

Booksellers & Trade Customers: Sign up for online bulk buying at trade.atlanticbooks.com for wholesale discounts

Booksellers: Create Account on our B2B Portal for wholesale discounts

Drug and Therapy Development for Triple Negative Breast Cancer

by Editor: Pravin Kendrekar , T&T Pharmaceuticals, Mumbai, India) , Editor: Vinayak Adimule (Angadi Institute of Technology and Management, India), Editor: Tara Hurst (Birmingham City University in Edgbaston, UK)
Save 12% Save 12%
Current price ₹12,809.00
Original price ₹14,548.00
Original price ₹14,548.00
Original price ₹14,548.00
(-12%)
₹12,809.00
Current price ₹12,809.00

Imported Edition - Ships in 18-21 Days

Free Shipping in India on orders above Rs. 500

Request Bulk Quantity Quote
+91
Hardcover: Hardcover
  • ISBN13: 9783527351756
  • Binding: Hardcover
  • Subject: N/A
  • Publisher: Wiley
  • Publisher Imprint: Wiley-VCH
  • Publication Date:
  • Pages: 320
  • Original Price: GBP 115.0
  • Language: English
  • Edition: N/A
  • Item Weight: 770 grams
  • BISAC Subject(s): Pharmacology

Drug and Therapy Development for Triple Negative Breast Cancer

The first comprehensive and up-to-date compilation of modern diagnostic and treatment methods for triple negative breast cancer

In Drug and Therapy Development for Triple Negative Breast Cancer, a team of distinguished practitioners delivers an in-depth and authoritative discussion of contemporary methods for treating triple negative breast cancer (TNBC). The editors have included material that covers its molecular causes, initial detection, diagnostic tools, treatment procedures, pharmacology, and new and experimental therapies—including nanotherapeutics and photothermal therapies.

As the first comprehensive compilation of modern treatment methods for TNBC, this reference is an unmatched source of information about current and future treatment approaches, including machine learning methods for earlier detection and more accurate diagnosis. Readers will also find: *A thorough introduction to HER receptors in breast cancers *Comprehensive explorations of the etiology and therapy of hormone receptor-positive breast cancer and the early-stage diagnosis of breast cancer *Application of artificial intelligence to breast cancer diagnosis *New insights on the role of DNA replication stress and genome instability in breast cancer

Perfect for medicinal and pharmaceutical chemists, Drug and Therapy Development for Triple Negative Breast Cancer will also benefit oncologists and professionals working in the pharmaceutical industry or in hospital settings.

Pravin Kendrekar works as a Scientist Advisor for White Collar Food & Beverages, Pune, India and T&T Pharmaceuticals, Mumbai, India.

Vinayak Adimule works at the Angadi Institute of Technology and Management in Belagavi, India.

Tara Hurst works in the School of Health Sciences at Birmingham City University in Edgbaston, UK.

Trusted for over 49 years

Family Owned Company

Secure Payment

All Major Credit Cards/Debit Cards/UPI & More Accepted

New & Authentic Products

India's Largest Distributor

Need Support?

Whatsapp Us